This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for treatment of chronic weight management, obesity and/or blood glucose control, including but not limited to dual agonist peptide product of SEQ ID NO. 1.
FREE ONE STOP SHOPPING MALL IN THE COMFORT OF YOUR OWN HOME.  ALL YOUR FAVORITE BRAND NAME STORES, EARN CASH AN DISCOUNTS FOR JUST SHOPPING ON LINE FROM YOUR FREE AGENT WEBSITE JUST FOLLOW THE INSTRU...